Yu Shyr

Yu Shyr

Vanderbilt University

H-index: 122

North America-United States

About Yu Shyr

Yu Shyr, With an exceptional h-index of 122 and a recent h-index of 65 (since 2020), a distinguished researcher at Vanderbilt University, specializes in the field of Biostatistics, Bioinformatics, Data Science.

His recent articles reflect a diverse array of research interests and contributions to the field:

NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma

Interoperability of phenome-wide multimorbidity patterns: a comparative study of two large-scale EHR systems

A large-scale meta-analysis reveals positive feedback between macrophages and T cells that sensitizes tumors to immunotherapy

scKWARN: Kernel-weighted-average robust normalization for single-cell RNA-seq data

Atezolizumab in Combination with carboplatin and survival outcomes in patients with metastatic triple-negative breast cancer: the TBCRC 043 phase 2 randomized clinical trial

EVPsort: an atlas of small ncRNA profiling and sorting in extracellular vesicles and particles

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients …

Telephone-Based Guideline-Directed Medical Therapy Optimization in Navajo Nation: The Hózhó Randomized Clinical Trial

Yu Shyr Information

University

Position

Director

Citations(all)

61763

Citations(since 2020)

23678

Cited By

44233

hIndex(all)

122

hIndex(since 2020)

65

i10Index(all)

457

i10Index(since 2020)

304

Email

University Profile Page

Vanderbilt University

Google Scholar

View Google Scholar Profile

Yu Shyr Skills & Research Interests

Biostatistics

Bioinformatics

Data Science

Top articles of Yu Shyr

Title

Journal

Author(s)

Publication Date

NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma

British journal of cancer

Michael Cecchini

James M Cleary

Yu Shyr

Joseph Chao

Nataliya Uboha

...

2024/2/24

Interoperability of phenome-wide multimorbidity patterns: a comparative study of two large-scale EHR systems

medRxiv

Nick Strayer

Tess J Vessels

Karmel W Choi

Siwei Zhang

Yajing Li

...

2024

A large-scale meta-analysis reveals positive feedback between macrophages and T cells that sensitizes tumors to immunotherapy

Cancer Research

Jing Yang

Qi Liu

Yu Shyr

2024/2/15

scKWARN: Kernel-weighted-average robust normalization for single-cell RNA-seq data

Bioinformatics

Chih-Yuan Hsu

Chia-Jung Chang

Qi Liu

Yu Shyr

2024/2/1

Atezolizumab in Combination with carboplatin and survival outcomes in patients with metastatic triple-negative breast cancer: the TBCRC 043 phase 2 randomized clinical trial

JAMA oncology

Brian D Lehmann

Vandana G Abramson

E Claire Dees

Payal D Shah

Tarah J Ballinger

...

2024/2/1

EVPsort: an atlas of small ncRNA profiling and sorting in extracellular vesicles and particles

Journal of Molecular Biology

Hua-chang Chen

Jing Wang

Robert J Coffey

James G Patton

Alissa M Weaver

...

2024/4/10

A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients …

JTO Clinical and Research Reports

Kathryn E Beckermann

Christine M Bestvina

Badi El Osta

Rachel E Sanborn

Hossein Borghaei

...

2024/2/1

Telephone-Based Guideline-Directed Medical Therapy Optimization in Navajo Nation: The Hózhó Randomized Clinical Trial

JAMA Internal Medicine

Lauren A Eberly

Ada Tennison

Daniel Mays

Chih-Yuan Hsu

Chih-Ting Yang

...

2024/4/7

FindAdapt: A python package for fast and accurate adapter detection in small RNA sequencing

PLoS computational biology

Hua-Chang Chen

Jing Wang

Yu Shyr

Qi Liu

2024/1/22

Abstract B040: NCI 10129: A Phase 2 Study of the PARP inhibitor Olaparib (AZD2281) in IDH1 and IDH2 mutant advanced solid tumors

NaN

Michael Cecchini

Mary Jo Pilat

Nataliya Uboha

Nilofer S Azad

May Cho

...

2023

Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19

JAMA oncology

Shuchi Gulati

Chih-Yuan Hsu

Surbhi Shah

Pankil K Shah

Rebecca Zon

...

2023/10/1

Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study

BMC Medical Research Methodology

Lejun Deng

Chih-Yuan Hsu

Yu Shyr

2023/2/23

The genetic landscape of familial pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Qi Liu

Yuan Zhou

Joy D Cogan

Daphne B Mitchell

Quanhu Sheng

...

2023/5/15

scDemultiplex: An iterative beta-binomial model-based method for accurate demultiplexing with hashtag oligos

Computational and Structural Biotechnology Journal

Li-Ching Huang

Lindsey K Stolze

Hua-Chang Chen

Alexander Gelbard

Yu Shyr

...

2023/1/1

OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC).

Oncologist

Kathryn Beckermann

Scott Haake

Anupama Reddy

Yu Shyr

W Kimryn Rathmell

...

2023/9/2

Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma

Cancer Research Communications

Kristina Fanucci

Mary Jo Pilat

Derek Shyr

Yu Shyr

Scott Boerner

...

2023/2/2

Abstract CT145: Olaparib+/-atezolizumab in patients with BRCA-mutated (BRCAmt) locally advanced unresectable or metastatic (advanced) breast cancer: an open-label, multicenter …

Cancer Research

Kristina A Fanucci

Mary Jo Pilat

Derek Shyr

Yu Shyr

Scott A Boerner

...

2023/4/14

Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer

Cancer Cell

Ananda M Rodilla

Rajesh M Valanparambil

Philip C Mack

Chih-Yuan Hsu

Jazz Cagan

...

2023/11/13

Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19

JAMA oncology

Ziad Bakouny

Chris Labaki

Punita Grover

Joy Awosika

Shuchi Gulati

...

2023/1/1

Impact of serial Intralesional steroid injections on idiopathic subglottic stenosis

The Laryngoscope

Matthew R Hoffman

Ankita Patro

Li‐Ching Huang

Sheau‐Chiann Chen

Lynn D Berry

...

2023/9

See List of Professors in Yu Shyr University(Vanderbilt University)